Eric Dobmeier's Net Worth
Eric Dobmeier's net worth is estimated to be at least $24,508,794.17 as of 11/20/2024. CoreStreet's estimation of Eric Dobmeier's net worth is based on their sale of stock and current holding of stock.
Eric Dobmeier is CEO at Chinook Therapeutics Inc. They have executed at least 38 trades of stock as per SEC Form 4 filings. Their most recent trade was for 23,800 units of KDNY stock on 04/24/2023. Their biggest sale was on 09/05/2013 when they sold 75,000 units of Seagen Inc stock for $3,198,000.00. They typically trade 3 times per year.
Total value of insider buys:
- $394,999.43
Total value of insider sells:
- $24,113,794.74
Most recent insider trade:
- April 24, 2023
Eric Dobmeier's Insider Trading History
| Chinook Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 24, 2023 | CEO | 23,800 | $21.58 | Sell | $513,604.00 |
Feb. 10, 2023 | CEO | 8,097 | $23.75 | Sell | $192,303.75 |
Jan. 30, 2023 | CEO | 25,000 | $24.54 | Sell | $613,500.00 |
Dec. 1, 2022 | CEO | 30,000 | $22.31 | Sell | $669,300.00 |
May 25, 2022 | CEO | 5,000 | $13.03 | Buy | $65,150.00 |
Sept. 20, 2021 | CEO | 2,000 | $12.00 | Buy | $24,000.00 |
Aug. 18, 2021 | CEO | 7,000 | $11.74 | Buy | $82,180.00 |
May 14, 2021 | CEO | 1,000 | $14.44 | Buy | $14,440.00 |
Dec. 8, 2020 | CEO | 2,000 | $13.24 | Buy | $26,480.00 |
Nov. 23, 2020 | CEO | 929 | $13.67 | Buy | $12,699.43 |
Nov. 19, 2020 | CEO | 500 | $13.50 | Buy | $6,750.00 |
Nov. 10, 2020 | CEO | 2,000 | $13.86 | Buy | $27,720.00 |
| Adaptive Biotechnologies Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 4, 2021 | Director | 10,000 | $57.34 | Sell | $573,400.00 |
Oct. 1, 2020 | Director | 10,000 | $48.53 | Sell | $485,300.00 |
July 6, 2020 | Director | 10,000 | $47.37 | Sell | $473,700.00 |
June 3, 2020 | Director | 5,000 | $39.79 | Sell | $198,950.00 |
May 19, 2020 | Director | 5,000 | $40.00 | Sell | $200,000.00 |
May 7, 2020 | Director | 5,000 | $35.00 | Sell | $175,000.00 |
| Atara Biotherapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 27, 2019 | Director | 2,000 | $19.50 | Buy | $39,000.00 |
March 17, 2016 | Director | 3,000 | $13.86 | Buy | $41,580.00 |
Dec. 16, 2015 | Director | 2,500 | $22.00 | Buy | $55,000.00 |
| Seagen Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 4, 2017 | COO | 3,729 | $58.75 | Sell | $219,078.75 |
Nov. 17, 2017 | COO | 35,000 | $58.25 | Sell | $2,038,750.00 |
Nov. 15, 2017 | COO | 9,600 | $57.80 | Sell | $554,880.00 |
Aug. 31, 2017 | COO | 25,000 | $52.24 | Sell | $1,306,000.00 |
Aug. 28, 2017 | COO | 5,343 | $47.89 | Sell | $255,876.27 |
Dec. 8, 2016 | COO | 12,500 | $65.92 | Sell | $824,000.00 |
Sept. 14, 2016 | COO | 22,918 | $54.04 | Sell | $1,238,488.72 |
Aug. 23, 2016 | COO | 12,589 | $48.00 | Sell | $604,272.00 |
Aug. 22, 2016 | COO | 5,411 | $46.59 | Sell | $252,098.49 |
Nov. 6, 2015 | COO | 17,452 | $42.50 | Sell | $741,710.00 |
Aug. 20, 2015 | COO | 8,548 | $42.02 | Sell | $359,186.96 |
May 8, 2015 | COO | 17,074 | $40.38 | Sell | $689,448.12 |
Jan. 21, 2014 | COO | 56,010 | $47.92 | Sell | $2,683,999.20 |
Sept. 10, 2013 | COO | 42,000 | $46.40 | Sell | $1,948,800.00 |
Sept. 5, 2013 | COO | 75,000 | $42.64 | Sell | $3,198,000.00 |
Aug. 19, 2013 | COO | 3,328 | $40.91 | Sell | $136,148.48 |
March 6, 2013 | COO | 100,000 | $29.68 | Sell | $2,968,000.00 |